Trend in approval of targeted biologics in the last two decades
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Huvudupphovsman: | Siddika, Khadiza |
---|---|
Övriga upphovsmän: | Ahmed, Syeda Maliha |
Materialtyp: | Lärdomsprov |
Språk: | English |
Publicerad: |
Brac University
2024
|
Ämnen: | |
Länkar: | http://hdl.handle.net/10361/24296 |
Liknande verk
-
Targeted therapeutic options in the treatment of Breast Cancer
av: Alam, Kazi Tasnuva
Publicerad: (2022) -
Study on anticancer drugs approved by the FDA from 2014 to 2023
av: Rattry, Faria Rahman
Publicerad: (2024) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
av: Tania, Umme
Publicerad: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
av: Jahan, Nusrat
Publicerad: (2024) -
Molecular biology : genes to proteins /
av: Tropp, Burton E.
Publicerad: (2008)